LDS/Medical Tests/MAML2 (11q21) Rearrangement, Mucoepidermoid Carcinoma (MEC), FISH, Tissue

MAML2 (11q21) Rearrangement, Mucoepidermoid Carcinoma (MEC), FISH, Tissue

The mastermind-like 2 (MAML2) gene, formed after chromosome translocation (t) (11;19)(q21;p13) or t(11;15)(q21;p26) results in the fusion CRTC1-MAML2 or CRTC3-MAML2 genes. The prevalence of these fused genes in mucoepidermoid carcinoma (MEC) is 40-80% and 5% respectively. MEC is a common cancer of the salivary glands, while rarely occurs in the breast, cervix, esophagus, lung, pancreas, skin, and thyroid. The CRTC1/MAML2 fusion transcript has been detected in more than 55 percent of patients with MEC of the salivary gland through several investigations involving fluorescence in situ hybridization (FISH). Due to the degree of histologic homology with other glandular tissues, diagnosing MEC of the salivary gland through histological investigation can be difficult.

The testing of the MAML2 rearrangement gene using FISH is helpful in the diagnosis and prognosis of the MEC of the salivary gland. The testing of MAML2 gene also facilitates grading the tumor into lower, intermediate, and higher grades. The higher the grade of salivary gland neoplasm the lower the chance of detection of MAML2 rearrangement and lower the chance of survival of patients, i.e. higher the detection of MAML2 rearrangement, the longer is the survival of the patient. Further, FISH can accurately distinguish MEC from its histologic mimics such as oncocytic cystadenoma, Warthin tumor, oncocytoma, oncocytic carcinoma, acinic cell carcinoma, and metastatic renal cell carcinoma.

  • Diagnosis and prognosis of mucoepidermoid carcinoma of the salivary gland
  • Grading of mucoepidermoid carcinoma into lower, intermediate, and higher grades
  • Diagnosis of mucoepidermoid carcinoma of different sites

Positive or abnormal:

if neoplastic clone carrying the MAML2 rearrangement is detected and if the percent of cells with an neoplastic clone exceed the normal cells or the cutoff for the MAML2 probe. A positive result confirms a diagnosis of mucoepidermoid carcinoma.

A negative result suggests no rearrangement of the MAML2 gene region at 11q21 indicating no diagnosis of mucoepidermoid carcinoma. However, this result does not exclude the diagnosis of MEC.

Negative, no rearrangement of the MAML2 gene region was identified

FISH (Fluorescent In-situ Hybridization).

FFPE (Formalin fixed paraffin embedded) tissue. 

Stability

  • FFPE is stable at room temperature indefinitely.
issue biopsy, Hematoxylin and Eosin staining, immunohistochemistry, polymerase chain reaction.
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login